ARS Pharmaceuticals, Inc.SPRYNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-13.04%
↓ 1280% below average
Average (22q)
-0.95%
Historical baseline
Range
High:355.00%
Low:-168.63%
Volatility
-55393.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -13.04% |
| Q2 2025 | -31.43% |
| Q1 2025 | -168.63% |
| Q4 2024 | 355.00% |
| Q3 2024 | -53.85% |
| Q2 2024 | -18.18% |
| Q1 2024 | -47.45% |
| Q4 2023 | 53.38% |
| Q3 2023 | 11.11% |
| Q2 2023 | -50.00% |
| Q1 2023 | 20.00% |
| Q4 2022 | -113.68% |
| Q3 2022 | -8.84% |
| Q2 2022 | 18.25% |
| Q1 2022 | 88.22% |
| Q4 2021 | -3.08% |
| Q3 2021 | 7.14% |
| Q2 2021 | -29.63% |
| Q1 2021 | -42.11% |
| Q4 2020 | 0.00% |
| Q2 2020 | -18.75% |
| Q1 2020 | 23.81% |
| Q4 2019 | 0.00% |